Search Results - "DIOMANDE, Fabien"

Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014 by Djingarey, Mamoudou H., Diomandé, Fabien V. K., Barry, Rodrigue, Kandolo, Denis, Shirehwa, Florence, Lingani, Clement, Novak, Ryan T., Tevi-Benissan, Carol, Perea, William, Preziosi, Marie-Pierre, LaForce, F. Marc

“…Background. A group A meningococcal conjugate vaccine (PsA-TT) was developed specifically for the African "meningitis belt" and was prequalified by the World…”
Get full text

Public Health Impact After the Introduction of PsA-TT: The First 4 Years by Diomandé, Fabien V. K., Djingarey, Mamoudou H., Daugla, Doumagoum M., Novak, Ryan T., Kristiansen, Paul A., Collard, Jean-Marc, Gamougam, Kadidja, Kandolo, Denis, Mbakuliyemo, Nehemie, Mayer, Leonard, Stuart, James, Clark, Thomas, Tevi-Benissan, Carol, Perea, William A., Preziosi, Marie-Pierre, LaForce, F. Marc, Caugant, Dominique, Messonnier, Nancy, Walker, Oladapo, Greenwood, Brian

“…Background. During the first introduction of a group A meningococcal vaccine (PsA-TT) in 2010–2011 and its rollout from 2011 to 2013, >150 million eligible…”
Get full text

Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010 by Ouandaogo, Claude-Roger, Yaméogo, Téné M, Diomandé, Fabien V.K, Sawadogo, Charles, Ouédraogo, Bassirou, Ouédraogo-Traoré, Rasmata, Pezzoli, Lorenzo, Djingarey, Mamoudou H, Mbakuliyemo, Nehémie, Zuber, Patrick L.F

“…Highlights ► Health problems detected were comparable with baseline data of the districts. ► Documented safety profile consistent with monovalent PS conjugate…”
Get full text

Monovalent type 2 OPV (mOPV2) management in the field: Interventions and lessons learned by Afsar, Ahmet, Mallya, Apoorva, Mohammed, Abdul Aziz Garba, Anand, Saumya, Diomande, Veh Kesse Fabien, Maufras du Châtellier, Gaël, Ather, Fazal

“…The polio endgame strategy calls for ending the use of and removal of all Sabin vaccines globally given the risks of generation and spread of cVDPVs. With the…”
Get full text

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data by Novak, Ryan T, Dr, Kambou, Jean Ludovic, MD, Diomandé, Fabien VK, MD, Tarbangdo, Tiga F, MSc, Ouédraogo-Traoré, Rasmata, Prof, Sangaré, Lassana, Prof, Lingani, Clement, MSc, Martin, Stacey W, MSc, Hatcher, Cynthia, MPH, Mayer, Leonard W, PhD, LaForce, F Marc, MD, Avokey, Fenella, MD, Djingarey, Mamoudou H, MD, Messonnier, Nancy E, MD, Tiendrébéogo, Sylvestre R, MD, Clark, Thomas A, MD

“…Summary Background An affordable, highly immunogenic Neisseria meningitidis serogroup A meningococcal conjugate vaccine (PsA–TT) was licensed for use in…”
Get full text

Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt by Tartof, Sara, Cohn, Amanda, Tarbangdo, Félix, Djingarey, Mamoudou H, Messonnier, Nancy, Clark, Thomas A, Kambou, Jean Ludovic, Novak, Ryan, Diomandé, Fabien V K, Medah, Isaïe, Jackson, Michael L

“…The optimal long-term vaccination strategies to provide population-level protection against serogroup A Neisseria meningitidis (MenA) are unknown. We developed…”
Get full text

Neisseria meningitidis serogroup W, Burkina Faso, 2012 by MacNeil, Jessica R, Medah, Isaïe, Koussoubé, Daouda, Novak, Ryan T, Cohn, Amanda C, Diomandé, Fabien V K, Yelbeogo, Denis, Kambou, Jean Ludovic, Tarbangdo, Tiga F, Ouédraogo-Traoré, Rasmata, Sangaré, Lassana, Hatcher, Cynthia, Vuong, Jeni, Mayer, Leonard W, Djingarey, Mamoudou H, Clark, Thomas A, Messonnier, Nancy E

“…In 2010, Burkina Faso became the first country to introduce meningococcal serogroup A conjugate vaccine (PsA-TT). During 2012, Burkina Faso reported increases…”
Get full text

Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali by Vannice, Kirsten S., Keita, Modibo, Sow, Samba O., Durbin, Anna P., Omer, Saad B., Moulton, Lawrence H., Yaméogo, Téné M., Zuber, Patrick L. F., Onwuchekwa, Uma, Sacko, Massambou, Diomandé, Fabien V. K., Halsey, Neal A.

“…Background. The monovalent meningococcal A conjugate vaccine (PsA-TT, MenAfriVac) was developed for use in the "meningitis belt" of sub-Saharan Africa. Mali…”
Get full text

Lessons Learned From Enhancing Vaccine Pharmacovigilance Activities During PsA-TT Introduction in African Countries, 2010–2013 by Diomandé, Fabien V. K., Yaméogo, Téné M., Vannice, Kirsten S., Preziosi, Marie-Pierre, Viviani, Simonetta, Ouandaogo, Claude-Roger, Keita, Modibo, Djingarey, Mamoudou H., Mbakuliyemo, Nehemie, Akanmori, Bartholomew Dicky, Sow, Samba O., Zuber, Patrick L. F.

“…Background. The rollout of the group A meningococcal vaccine, PsA-TT, in Africa's meningitis belt countries represented the first introduction of a vaccine…”
Get full text

Polio Surge Capacity Support Program Contributions to Building Country Capacities in Support of Polio Outbreak Preparedness and Response: Lessons Learned and Remaining Challenges by Abebe, Fikru, Eboh, Victor Anochieboh, Weldetsadik, Mesfin Belew, Kone, Ibrahima, Kebede, Tessema Assegid, Harries, Paul Thomas, Diomande, Veh Kesse Fabien

“…Despite coordinated efforts at global level, through the Global Polio Eradication Initiative (GPEI), poliomyelitis disease (Polio) is still a major public…”
Get full text

Correction: Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt by Tartof, Sara, Cohn, Amanda, Tarbangdo, Félix, Djingarey, Mamoudou H, Messonnier, Nancy, Clark, Thomas A, Kambou, Jean Ludovic, Novak, Ryan, Diomandé, Fabien V K, Medah, Isaïe, Jackson, Michael L

“…[This corrects the article DOI: 10.1371/journal.pone.0063605.]…”
Get full text

Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity by Kristiansen, Paul A., Diomandé, Fabien, Ba, Absatou Ky, Sanou, Idrissa, Ouédraogo, Abdoul—Salam, Ouédraogo, Rasmata, Sangaré, Lassana, Kandolo, Denis, Aké, Flavien, Saga, Inger Marie, Clark, Thomas A., Misegades, Lara, Martin, Stacey W., Thomas, Jennifer Dolan, Tiendrebeogo, Sylvestre R., Hassan-King, Musa, Djingarey, Mamoudou H., Messonnier, Nancy E., Préziosi, Marie-Pierre, LaForce, F. Marc, Caugant, Dominique A.

“…Background. The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of…”
Get full text

The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d'Ivoire's Drug Access Initiative by DIOMANDE, Fabien V. K, BISSAGNENE, Emmanuel, NKENGASONG, John N, MAURICE, Chantal, MONGA, Ben, LAGA, Marie, NOLAN, Monica L

“…To describe the cost and outcome associated with the use of CD4 cell count and viral load tests as part of screening strategies to identify persons eligible…”
Get full text

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine by Kristiansen, Paul A., Diomandé, Fabien, Wei, Stanley C., Ouédraogo, Rasmata, Sangaré, Lassana, Sanou, Idrissa, Kandolo, Denis, Kaboré, Pascal, Clark, Thomas A., Ouédraogo, Abdoul-Salam, Absatou, Ki Ba, Ouédraogo, Charles D., Hassan-King, Musa, Thomas, Jennifer Dolan, Hatcher, Cynthia, Djingarey, Mamoudou, Messonnier, Nancy, Préziosi, Marie-Pierre, LaForce, Marc, Caugant, Dominique A.

“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience by Djingarey, Mamoudou H, Barry, Rodrigue, Bonkoungou, Mete, Tiendrebeogo, Sylvestre, Sebgo, Rene, Kandolo, Denis, Lingani, Clement, Preziosi, Marie-Pierre, Zuber, Patrick L.F, Perea, William, Hugonnet, Stéphane, Dellepiane de Rey Tolve, Nora, Tevi-Benissan, Carole, Clark, Thomas A, Mayer, Leonard W, Novak, Ryan, Messonier, Nancy E, Berlier, Monique, Toboe, Desire, Nshimirimana, Deo, Mihigo, Richard, Aguado, Teresa, Diomandé, Fabien, Kristiansen, Paul A, Caugant, Dominique A, LaForce, F. Marc

“…Highlights ► Introduction of a new meningitis vaccine in Burkina Faso in 2010 was a huge success. ► More than 11 million Burkinabe (100% target population)…”
Get full text

Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac by Kristiansen, Paul A, Ba, Absatou Ky, Ouédraogo, Abdoul-Salam, Sanou, Idrissa, Ouédraogo, Rasmata, Sangaré, Lassana, Diomandé, Fabien, Kandolo, Denis, Saga, Inger Marie, Misegades, Lara, Clark, Thomas A, Préziosi, Marie-Pierre, Caugant, Dominique A

“…The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, is currently being introduced throughout the African meningitis belt. In…”
Get full text

Carriage of Neisseria lactamica in 1- to 29-Year-Old People in Burkina Faso: Epidemiology and Molecular Characterization by KRISTIANSEN, Paul A, DIOMANDE, Fabien, PREZIOSI, Marie-Pierre, MARC LAFORCE, F, CAUGANT, Dominique A, OUEDRAOGO, Rasmata, SANOU, Idrissa, SANGARE, Lassana, OUEDRAOGO, Abdoul-Salam, KY BA, Absatou, KANDOLO, Denis, DOLAN THOMAS, Jennifer, CLARK, Thomas A

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine by Kristiansen, Paul A, Ba, Absatou Ky, Sanou, Idrissa, Ouédraogo, Abdoul-Salam, Ouédraogo, Rasmata, Sangaré, Lassana, Diomandé, Fabien, Kandolo, Denis, Thomas, Jennifer Dolan, Clark, Thomas A, Laforce, Marc, Caugant, Dominique A

“…The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of the 1-29-year-olds in…”
Get full text

MenAfriNet: A Network Supporting Case-Based Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Africa by Patel, Jaymin C, Soeters, Heidi M, Diallo, Alpha Oumar, Bicaba, Brice W, Kadadé, Goumbi, Dembélé, Assétou Y, Acyl, Mahamat A, Nikiema, Christelle, Lingani, Clement, Hatcher, Cynthia, Acosta, Anna M, Thomas, Jennifer D, Diomande, Fabien, Martin, Stacey, Clark, Thomas A, Mihigo, Richard, Hajjeh, Rana A, Zilber, Catherine H, Aké, Flavien, Mbaeyi, Sarah A, Wang, Xin, Moisi, Jennifer C, Ronveaux, Olivier, Mwenda, Jason M, Novak, Ryan T

“…Meningococcal meningitis remains a significant public health threat, especially in the African meningitis belt where Neisseria meningitidis serogroup A…”
Get full text

Evaluation of acute flaccid paralysis surveillance performance before and during the 2014-2015 Ebola virus disease outbreak in Guinea and Liberia by Umutesi, Grace, Moon, Troy D, Makam, Jeevan Kumar, Diomande, Fabien, Cherry, Charlotte Buehler, Tuopileyi Ii, Roland No, Zakari, Wambai, Craig, Allen Scott

“…the number of wild poliomyelitis cases, worldwide, dropped from 350,000 cases in 1988 to 33 in 2018. Acute flaccid paralysis (AFP) surveillance is a key…”
Get full text